Post

ME/CFS Science
@mecfsscience.org

1) 🇩🇪 Scientists and clinicians based at institutions located in Germany can apply for the 2026 research funding programme of the ME/CFS Research Foundation. €2 million is available for new research projects. The deadline for submitting proposals is 30 April 2026.

ME/CFS Science
@mecfsscience.org

2) The focus of the call is on: - Disease mechanisms behind key ME/CFS symptoms such as post-exertional malaise (PEM) - Biomarkers for diagnosis and prognosis - Innovative, disease mechanism-targeted drugs and treatment approaches

ME/CFS Science
@mecfsscience.org

3) Projects in the field of health services or epidemiological research, however, are not eligible for funding under this year's programme. Submissions will be evaluated by a jury of international experts and the Foundation's science team.

0 reposts5 likes

ME/CFS Science
@mecfsscience.org

4) The announcement on the allocation of funds is expected around 30 June 2026. Funded projects must begin their work between July and September of this year.

ME/CFS Science
@mecfsscience.org

5) More info about this call and how to apply is available here:

mecfs-research.orgApply now: ME/CFS Research Foundation launches 2026 research funding programmeAb heute haben Wissenschaftler*innen und Kliniker*innen in Deutschland die Möglichkeit sich auf unser Forschungsförderprogramm 2026 zu bewerben. Insgesamt stehen 2 Millionen Euro für neue Forschungsprojekte zur Verfügung. Davon sind 1,5 Mio. Euro für klinische Forschung und 0,5 Mio. Euro für Grundla
ME/CFS Science
@mecfsscience.org

We did a summary of the paper when it came out as a preprint, a while ago: bsky.app/profile/mecf...

ME/CFS Science@mecfsscience.org

1) In a new pre-print, the lab of Bhupesh Prusty reports that antibodies (IgG) from ME/CFS patients cause mitochondrial fragmentation in endothelial cells. This was not seen in antibodies from MS patients or healthy controls.